Literature DB >> 27699453

Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.

Georgia Dalagiorgou1, Christina Piperi1, Christos Adamopoulos1, Urania Georgopoulou2, Antonios N Gargalionis1, Anastasia Spyropoulou1, Ilianna Zoi1, Marjan Nokhbehsaim3, Anna Damanaki3, James Deschner3, Efthimia K Basdra4, Athanasios G Papavassiliou5.   

Abstract

Polycystin-1 (PC1) has been proposed as a chief mechanosensing molecule implicated in skeletogenesis and bone remodeling. Mechanotransduction via PC1 involves proteolytic cleavage of its cytoplasmic tail (CT) and interaction with intracellular pathways and transcription factors to regulate cell function. Here we demonstrate the interaction of PC1-CT with JAK2/STAT3 signaling axis in mechanically stimulated human osteoblastic cells, leading to transcriptional induction of Runx2 gene, a master regulator of osteoblastic differentiation. Primary osteoblast-like PC1-expressing cells subjected to mechanical-stretching exhibited a PC1-dependent increase of the phosphorylated(p)/active form of JAK2. Specific interaction of PC1-CT with pJAK2 was observed after stretching while pre-treatment of cells with PC1 (anti-IgPKD1) and JAK2 inhibitors abolished JAK2 activation. Consistently, mechanostimulation triggered PC1-mediated phosphorylation and nuclear translocation of STAT3. The nuclear phosphorylated(p)/DNA-binding competent pSTAT3 levels were augmented after stretching followed by elevated DNA-binding activity. Pre-treatment with a STAT3 inhibitor either alone or in combination with anti-IgPKD1 abrogated this effect. Moreover, PC1-mediated mechanostimulation induced elevation of Runx2 mRNA levels. ChIP assays revealed direct regulation of Runx2 promoter activity by STAT3/Runx2 after mechanical-stretching that was PC1-dependent. Our findings show that mechanical load upregulates expression of Runx2 gene via potentiation of PC1-JAK2/STAT3 signaling axis, culminating to possibly control osteoblastic differentiation and ultimately bone formation.

Entities:  

Keywords:  Gene regulation; JAK/STAT pathway; Mechanosensor; Mechanotransduction; Osteoblastic differentiation; Polycystin-1; Runx2

Mesh:

Substances:

Year:  2016        PMID: 27699453     DOI: 10.1007/s00018-016-2394-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  52 in total

Review 1.  Cellular and molecular mechanisms of bone remodeling.

Authors:  Liza J Raggatt; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 2.  Mechanotransduction in osteoblast regulation and bone disease.

Authors:  Katerina K Papachroni; Demetrios N Karatzas; Kostas A Papavassiliou; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Trends Mol Med       Date:  2009-04-08       Impact factor: 11.951

3.  PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.

Authors:  Anil Kumar Bhunia; Klaus Piontek; Alessandra Boletta; Lijuan Liu; Feng Qian; Pei Ning Xu; F Joseph Germino; Gregory G Germino
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

4.  Girdin/GIV is upregulated by cyclic tension, propagates mechanical signal transduction, and is required for the cellular proliferation and migration of MG-63 cells.

Authors:  Jiang-Tian Hu; Yan Li; Bing Yu; Guo-Jie Gao; Ting Zhou; Song Li
Journal:  Biochem Biophys Res Commun       Date:  2015-07-07       Impact factor: 3.575

5.  Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1.

Authors:  O Ibraghimov-Beskrovnaya; N O Bukanov; L C Donohue; W R Dackowski; K W Klinger; G M Landes
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

6.  Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.

Authors:  Zhousheng Xiao; Shiqin Zhang; Li Cao; Ni Qiu; Valentin David; L Darryl Quarles
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters.

Authors:  Jun Xu; Derek C Cole; Chao-Pei Betty Chang; Ramzi Ayyad; Magda Asselin; Wenshan Hao; James Gibbons; Scott A Jelinsky; Kathryn A Saraf; Kaapjoo Park
Journal:  J Med Chem       Date:  2008-06-25       Impact factor: 7.446

Review 8.  Runx2: of bone and stretch.

Authors:  Panos G Ziros; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Int J Biochem Cell Biol       Date:  2007-06-26       Impact factor: 5.085

9.  OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts.

Authors:  Stephanie Jerman; Heather H Ward; Rebecca Lee; Carla A M Lopes; Andrew M Fry; Mary MacDougall; Angela Wandinger-Ness
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

10.  HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.

Authors:  Michalis V Karamouzis; Georgia Dalagiorgou; Urania Georgopoulou; Afroditi Nonni; Michalis Kontos; Athanasios G Papavassiliou
Journal:  Oncotarget       Date:  2016-02-02
View more
  18 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

Review 3.  The role of transient receptor potential polycystin channels in bone diseases.

Authors:  Maria A Katsianou; Foteini G Skondra; Antonios N Gargalionis; Christina Piperi; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

Review 4.  Molecular mechanisms of mechanotransduction in psoriasis.

Authors:  Lina S Malakou; Antonios N Gargalionis; Christina Piperi; Evangelia Papadavid; Athanasios G Papavassiliou; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

5.  Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis.

Authors:  Zhousheng Xiao; Jerome Baudry; Li Cao; Jinsong Huang; Hao Chen; Charles R Yates; Wei Li; Brittany Dong; Christopher M Waters; Jeremy C Smith; L Darryl Quarles
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

6.  PKD1 alleviates oxidative stress-inhibited osteogenesis of rat bone marrow-derived mesenchymal stem cells through TAZ activation.

Authors:  Tongtong Chen; Hanqi Wang; Chaoyin Jiang; Yong Lu
Journal:  J Cell Biochem       Date:  2021-08-18       Impact factor: 4.480

7.  Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans.

Authors:  Judilyn Fuentes-Duculan; Kathleen M Bonifacio; Mayte Suárez-Fariñas; Norma Kunjravia; Sandra Garcet; Tristan Cruz; Claire Q F Wang; Hui Xu; Patricia Gilleadeau; Mary Sullivan-Whalen; Michael H Tirgan; James G Krueger
Journal:  Exp Dermatol       Date:  2017-02-28       Impact factor: 3.960

8.  Polycystin-2 Is Required for Chondrocyte Mechanotransduction and Traffics to the Primary Cilium in Response to Mechanical Stimulation.

Authors:  Clare L Thompson; Megan McFie; J Paul Chapple; Philip Beales; Martin M Knight
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 6.208

9.  Polycystins and mechanotransduction in bone.

Authors:  Antonios N Gargalionis; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Oncotarget       Date:  2017-11-13

10.  Mineral bone disease in autosomal dominant polycystic kidney disease.

Authors:  Berenice Gitomer; Renata Pereira; Isidro B Salusky; Jason W Stoneback; Tamara Isakova; Xuan Cai; Lorien S Dalrymple; Norma Ofsthun; Zhiying You; Harmut H Malluche; Franklin Maddux; Diana George; Vicente Torres; Arlene Chapman; Theodore I Steinman; Myles Wolf; Michel Chonchol
Journal:  Kidney Int       Date:  2020-09-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.